lysine has been researched along with 4-aminophenylethyl-1,4,7,10-tetraazacyclodecane-n,n',n'',n'''-tetraacetic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, RC; DePalatis, LR; Frazier, KA; Kotite, NJ | 1 |
1 other study(ies) available for lysine and 4-aminophenylethyl-1,4,7,10-tetraazacyclodecane-n,n',n'',n'''-tetraacetic acid
Article | Year |
---|---|
Lysine reduces renal accumulation of radioactivity associated with injection of the [177Lu]alpha-[2-(4-aminophenyl) ethyl]-1,4,7,10-tetraaza-cyclodecane-1,4,7,10-tetraacetic acid-CC49 Fab radioimmunoconjugate.
Topics: Aniline Compounds; Animals; Antibodies, Monoclonal; Female; Heterocyclic Compounds; Immunoconjugates; Immunoglobulin Fab Fragments; Kidney; Lutetium; Lysine; Mice; Mice, Inbred BALB C; Radioisotopes; Tissue Distribution | 1995 |